SIM
LPCN icon

Spark Investment Management’s Lipocine LPCN Stock Holding History

Spark Investment Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,041
Closed -$34K – 464
2019
Q2 		$34K Sell
1,041
-1,965
-65% -$60.6K ﹤0.01% 532
2019
Q1 		$118K Buy
+3,006
New +$92.2K 0.01% 561
2018
Q1 		– Sell
-741
Closed -$43K – 666
2017
Q4 		$43K Buy
+741
New +$46.1K ﹤0.01% 663

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spark Investment Management's LPCN Position: Q3 2019 in Review

Spark Investment Management sold out of Lipocine (LPCN) in Q3 2019, closing a stake of 1,041 shares — an estimated $34K sold.

Spark Investment Management first reported a position in LPCN in Q4 2017 and held it in 3 quarters. The position peaked at $118K in Q1 2019. 30 funds tracked by Wall St. Rank hold LPCN as of Q3 2019.

  • Spark Investment Management reported no remaining Lipocine position as of Q3 2019 after selling out during the quarter.
  • Spark Investment Management sold 1,041 Lipocine shares in Q3 2019, an estimated $34K.
  • Spark Investment Management first reported a position in Lipocine in Q4 2017 and held it in 3 quarters.
  • Spark Investment Management's Lipocine position peaked at $118K in Q1 2019.
  • 30 funds tracked by Wall St. Rank held Lipocine as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.